Literature DB >> 21047881

Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment.

Haobo Zhang1, Julian N Trollor, Wei Wen, Wanlin Zhu, John D Crawford, Nicole A Kochan, Melissa J Slavin, Henry Brodaty, Simone Reppermund, Kristan Kang, Karen A Mather, Perminder S Sachdev.   

Abstract

The basal forebrain area (BFA) is closely connected to the hippocampus by virtue of cholinergic neuronal projections. Structural neuroimaging studies have shown reduced volumes of both structures in Alzheimer's disease and its prodromal stage mild cognitive impairment (MCI), but generally not in the same investigation. By combining voxel based morphometry and region of interest methods, we measured the grey matter (GM) volumes of the two brain regions with the goal of elucidating their contributions to MCI and its two subtypes (amnestic MCI and non-amnestic MCI) in an elderly epidemiological sample. The results replicated previous findings that the atrophies of both brain regions were associated with an increased likelihood of MCI and its two subtypes. However, in a regression model for the prediction of MCI with GM volumes for both regions used as predictors, only hippocampal atrophy remained significant. Two possible interpretations for this pattern of results were discussed. One is that the observed correlation between BFA atrophy and MCI is spurious and due to the hippocampal atrophy correlated with both. Alternatively, our observation is consistent with the possibility that BFA atrophy has a causal effect on MCI, which is mediated via its influence on hippocampal atrophy. Furthermore, we found that the left hippocampal atrophy had a stronger effect than the right hippocampus and bilateral BFA in the prediction of amnestic MCI occurrence when the four unilateral areas were entered into one regression model. In addition, a slight but statistically significant difference was found in the left hippocampal volume between APOE ε4 allele carriers and non-carriers, consistent with prior studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047881     DOI: 10.1136/jnnp.2010.217133

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

Review 1.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 2.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

3.  Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.

Authors:  Jose L Cantero; Laszlo Zaborszky; Mercedes Atienza
Journal:  Cereb Cortex       Date:  2017-08-01       Impact factor: 5.357

Review 4.  Involvement of brain-derived neurotrophic factor in late-life depression.

Authors:  Yogesh Dwivedi
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-19       Impact factor: 4.105

5.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

6.  Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.

Authors:  Beata Ferencz; Sari Karlsson; Grégoria Kalpouzos
Journal:  Int J Alzheimers Dis       Date:  2012-04-09

7.  The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI.

Authors:  Gábor Csukly; Enikő Sirály; Zsuzsanna Fodor; András Horváth; Pál Salacz; Zoltán Hidasi; Éva Csibri; Gábor Rudas; Ádám Szabó
Journal:  Front Aging Neurosci       Date:  2016-03-30       Impact factor: 5.750

8.  Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.

Authors:  Youmei Xie; Rick B Meeker; Stephen M Massa; Frank M Longo
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

Review 9.  Sleep-Based Interventions in Alzheimer's Disease: Promising Approaches from Prevention to Treatment along the Disease Trajectory.

Authors:  Susanna Cordone; Serena Scarpelli; Valentina Alfonsi; Luigi De Gennaro; Maurizio Gorgoni
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19

10.  Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.

Authors:  Lin Zhuang; Perminder S Sachdev; Julian N Trollor; Simone Reppermund; Nicole A Kochan; Henry Brodaty; Wei Wen
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.